Regional anesthesia in the anticoagulated patient with pre-existing neuropathy
Stem
A 66-year-old man, 95 kg, needs open reduction and internal fixation of an ankle fracture with a thigh tourniquet. He has long-standing type 2 diabetes with numbness of both feet to mid-calf and absent ankle reflexes, and he finished oxaliplatin chemotherapy for colon cancer a year ago. He takes apixaban 5 mg twice daily for atrial fibrillation; his last dose was 36 hours ago. Creatinine is normal. He asks for "the nerve block, not a breathing tube."
Question
Will you do a regional anesthetic for him, and how?
Ideal answer
HeadlineYes, a peripheral block, not a spinal: his high-dose apixaban needs 72 hours off for neuraxial,1 and his nerves are vulnerable.
- Examine and document his baseline deficits, because a neuropathy found only after surgery is impossible to attribute.2
- Explain the double crush; decide together. With diabetes and oxaliplatin, a needle, high concentration or tourniquet is a second insult a healthy nerve would tolerate;2 evidence is limited.
- Popliteal sciatic and saphenous: superficial and compressible. At 36 hours a spinal is out; for these the guideline lets me decide on compressibility, vascularity and bleeding consequences.1
- Ultrasound, not a stimulator alone; extraneural, dilute, no epinephrine. Diabetic nerves can need high currents to respond,2 and are already prone to ischemia; lowest effective concentration and volume.2
- Minimal tourniquet; light sedation, general anesthetic backup. Pressure and time kept to a minimum; neuro exam rechecked as the block wears off.
Breaking down the answer
- Document before you touch — a thorough baseline neurologic exam is vital;2 subclinical diabetic neuropathy is common, nearly all diabetics have abnormal nerve conduction, and polyneuropathy affects more than 50% with long-standing disease.2
- Double crush — chronic neural compromise from mechanical, ischemic, toxic, metabolic or autoimmune causes may increase the risk of further injury from a second insult.2 That is why I reduce every other risk, positioning included.
- The anticoagulant still decides the technique — ASRA's fifth edition applies neuraxial intervals to deep plexus and deep peripheral blocks; other blocks are judged on site compressibility, vascularity and bleeding consequences.1 Had he stopped low-dose apixaban, 36 hours would have been enough.1
- Ultrasound over stimulation — in diabetics, a weak or absent motor response at high current has been reported despite perineural needle tips, and animal data link hyperglycemia with intraneural injection during nerve stimulation.2 Proof that ultrasound is safer is still lacking.
- Expect a longer block — diabetic nerves are more sensitive to local anesthetic, and blocks last longer;2 I warn him and protect the numb foot.
- Neuraxial is not banned in neuropathy — in 567 patients with peripheral neuropathy given neuraxial anesthesia, 0.4% had new or worse deficits, higher than in the general population but rare.2 In 139 patients with central nervous system disease, none worsened.2
Follow-up question
Twenty-two hours later, his foot is still numb and he cannot dorsiflex his ankle, though his popliteal block was expected to last about 16 hours. The splint is tight. What do you do?
Follow-up answer
HeadlineA possible new nerve injury, or still a prolonged block; I examine him against my written baseline and tell him and the surgeon.
The surgeon loosens or splits the splint at once and looks for compartment syndrome or a hematoma, especially if his apixaban has been restarted. A deficit that is progressing or fits a surgical lesion is investigated now. Otherwise neurology joins, and nerve studies at the right time localize the lesion and separate the old neuropathy from a new one, following the ASRA advisory's evaluation algorithm.3 I reassess daily and document every exam.
Pitfalls that cost points
- Writing "neuro intact" over a known neuropathy.
- Applying the 72-hour neuraxial interval to a superficial compressible block, or ignoring the drug entirely.
Rapid-fire
Q: Which chemotherapy agents cause neuropathy? A: Cisplatin, oxaliplatin and carboplatin cause a painful sensory neuropathy; vincristine and paclitaxel a mixed sensorimotor one.2
Q: Why was epidural traditionally preferred to spinal in multiple sclerosis? A: White-matter local anesthetic concentration after an epidural is about one-quarter of that after an intrathecal dose.2
Q: When must the first postoperative high-dose apixaban dose wait after a deep block? A: At least 24 hours after needle placement or catheter removal.1
Q: What did the second ASRA advisory add for nerve-injured patients? A: Revised evaluation algorithms with imaging and neurophysiologic testing, and pharmacologic and rehabilitation advice for neuropathic pain.3
Numbers to know
| Item | Value |
|---|---|
| High-dose apixaban before neuraxial or deep block | ≥72 h1 |
| Low-dose apixaban before neuraxial or deep block | ≥36 h1 |
| Diabetic polyneuropathy | 4–8% at diagnosis; >50% with long-standing diabetes2 |
| Neuraxial in peripheral neuropathy | 2/567 (0.4%) new or worse deficits2 |
| Neuraxial in CNS disease | 0/139 new deficits2 |
Links
- Neuraxial blocks and anticoagulants (ASRA), Femoral, adductor canal and popliteal blocks, Peripheral nerve injury and positioning, Diabetes mellitus and perioperative glucose, Bone cement, tourniquets and hip fracture
- Second ASRA Practice Advisory on Neurologic Complications (2015); ASRA antithrombotic guidelines, fifth edition (2025)
Sources
- 1.ASRA Guidelines for Regional Anesthesia with Antithrombotic or Thrombolytic Therapy 5th Edition - Summary of Recommendations · Guideline Central / ASRA Pain Medicine, 2025 · guidelinecentral.comFifth-edition intervals for apixaban and the rule for deep versus other plexus and peripheral blocks; matches the neuraxial-anticoagulation-guidelines page.
- 2.Regional Anesthesia in the Patient with Preexisting Neurologic Disease · NYSORA · nysora.comDouble-crush concept, diabetic and chemotherapy-induced neuropathy, nerve stimulation in diabetes, neuraxial outcomes in peripheral neuropathy (567 patients) and CNS disease (139 patients), multiple sclerosis.
- 3.The Second ASRA Practice Advisory on Neurologic Complications Associated With Regional Anesthesia and Pain Medicine · ASRA Pain Medicine, 2015 · asra.comASRA News summary by Joseph M. Neal of the advisory published in Reg Anesth Pain Med 2015.
Facts on this page were checked against these sources on Oct 16, 2026. Guidelines change; confirm doses against current institutional protocols.